-46.8%
PINS vs MRNA
+455.8%
-502.6%
-57.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.7% | +0.7% | +2.0% | +2.7% |
| 7D | -9.9% | -8.2% | -1.7% | -9.7% |
| 30D | -20.9% | +125.6% | -146.5% | -23.9% |
| 3M | -13.7% | +197.1% | -210.8% | -19.2% |
| 6M | -3.0% | +148.5% | -151.5% | -7.8% |
| YTD | -27.5% | +363.3% | -390.7% | -35.5% |
| 1Y | -46.8% | +462.0% | -508.8% | -53.0% |
| All | -46.8% | +455.8% | -502.6% | -53.0% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling